SEC Comment Letter 0000000000-23-010609 to BIOXYTRAN, INC (BIXT) (CIK 0001445815) (BIXT)
BIOXYTRAN, INC (BIXT) (CIK 0001445815)
Date: Sept. 26, 2023 · CIK: 0001445815 · Accession: 0000000000-23-010609
AI Filing Summary & Sentiment
File numbers found in text: 333-274576
Letter
United States securities and exchange commission logo September 26, 2023 David Platt, Ph.D. Chief Executive Officer Bioxytran, Inc. 75 Second Ave., Suite 605 Needham, MA 02494 Re:Bioxytran, Inc. Registration Statement on Form S-1 Filed September 19, 2023 File No. 333-274576 Dear David Platt: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jason Drory at 202-551-8342 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Robert J. Burnett
Show Raw Text
United States securities and exchange commission logo
September 26, 2023
David Platt, Ph.D.
Chief Executive Officer
Bioxytran, Inc.
75 Second Ave., Suite 605
Needham, MA 02494
Re:Bioxytran, Inc.
Registration Statement on Form S-1
Filed September 19, 2023
File No. 333-274576
Dear David Platt:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jason Drory at 202-551-8342 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Robert J. Burnett